Lessons for cardiac regeneration and repair through development

Trends in Molecular Medicine

Volumn 16, Issue 9, 2010, Pages 426-434

  Alexander, Jeffrey M ^a,b   Bruneau, Benoit G ^a,b,c  

^a GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

CELL DIFFERENTIATION; CELL REGENERATION; CELL TRANSPLANTATION; EMBRYONIC STEM CELL; HEART DEVELOPMENT; HEART MUSCLE CELL; HUMAN; NONHUMAN; POSTNATAL DEVELOPMENT; REVIEW; STEM CELL; TISSUE REGENERATION; TISSUE REPAIR;

ANIMALS; CELL DIFFERENTIATION; HEART; HUMANS; MYOCARDIUM; REGENERATION; REGENERATIVE MEDICINE; STEM CELLS;

EID: 77956266191     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2010.06.003     Document Type: Review

References (84)

1. Lloyd-Jones, D. et al. (2010) Heart disease and stroke statistics - 2010 update. A report from the American Heart Association. Circulation 121, e46-e215.
2. Murry C.E., et al. Cell-based cardiac repair: reflections at the 10-year point. Circulation 2005, 112:3174-3183.
3. Hansson E.M., et al. Regeneration next: toward heart stem cell therapeutics. Cell Stem Cell 2009, 5:364-377.
4. Laflamme M.A., Murry C.E. Regenerating the heart. Nat. Biotechnol. 2005, 23:845-856.
5. Alvarez-Dolado M., et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003, 425:968-973.
6. Reinecke H., et al. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J. Mol. Cell Cardiol. 2002, 34:241-249.
7. Murry C.E., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004, 428:664-668.
8. Balsam L.B., et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004, 428:668-673.
9. Nygren J.M., et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 2004, 10:494-501.
10. Reinecke H., et al. Electromechanical coupling between skeletal and cardiac muscle: implications for infarct repair. J. Cell Biol. 2000, 149:731-740.
11. Menasche P., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 2003, 41:1078-1083.
12. Murry C.E., Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 2008, 132:661-680.
13. Min J.Y., et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J. Appl. Physiol. 2002, 92:288-296.
14. Min J.Y., et al. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J. Thorac. Cardiovasc. Surg. 2003, 125:361-369.
15. Laflamme M.A., et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am. J. Pathol. 2005, 167:663-671.
16. Kehat I., et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol. 2004, 22:1282-1289.
17. Xue T., et al. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 2005, 111:11-20.
18. Laflamme M.A., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 2007, 25:1015-1024.
19. Caspi O., et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J. Am. Coll. Cardiol. 2007, 50:1884-1893.
20. Leor J., et al. Human embryonic stem cell transplantation to repair the infarcted myocardium. Br. Med. J. 2007, 93:1278-1284.
21. Song H., et al. Interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue. Proc. Natl. Acad. Sci. U. S. A. 2009, 107:3329-3334.
22. van Laake L.W., et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res. 2007, 1:9-24.
23. van Laake L.W., et al. Improvement of mouse cardiac function by hESC-derived cardiomyocytes correlates with vascularity but not graft size. Stem Cell Res. 2009, 3:106-112.
24. Kattman S.J., et al. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev. Cell 2006, 11:723-732.
25. Moretti A., et al. Multipotent embryonic Isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006, 127:1151-1165.
26. Wu S.M., et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 2006, 127:1137-1150.
27. Yang L., et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 2008, 453:524-528.
28. Bu L., et al. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 2009, 460:113-117.
29. Srivastava D. Making or breaking the heart: from lineage determination to morphogenesis. Cell 2006, 126:1037-1048.
30. Buckingham M., et al. Building the mammalian heart from two sources of myocardial cells. Nat. Rev. Genet. 2005, 6:826-835.
31. Kelly R.G., et al. The arterial pole of the mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm. Dev. Cell 2001, 1:435-440.
32. Meilhac S.M., et al. The clonal origin of myocardial cells in different regions of the embryonic mouse heart. Dev. Cell 2004, 6:685-698.
33. Cai C.L., et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev. Cell 2003, 5:877-889.
34. Ma Q., et al. Reassessment of Isl1 and Nkx2-5 cardiac fate maps using a Gata4-based reporter of Cre activity. Dev. Biol. 2008, 323:98-104.
35. Prall O.W.J., et al. An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation. Cell 2007, 128:947-959.
36. Domian I.J., et al. Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science 2009, 326:426-429.
37. Harvey R.P., et al. Patterning the vertebrate heart. Nat. Rev. Genet. 2002, 3:544-556.
38. Brade T., et al. The role of Wnt signaling in cardiac development and tissue remodelling in the mature heart. Cardiovasc. Res. 2006, 72:198-209.
39. Cohen E.D., et al. Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis, and progenitor self-renewal. Development 2008, 135:789-798.
40. Qyang Y., et al. The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway. Cell Stem Cell 2007, 1:165-179.
41. Kwon C., et al. Canonical Wnt signaling is a positive regulator of mammalian cardiac progenitors. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:10894-10899.
42. Naito A.T., et al. Developmental stage-specific biphasic roles of Wnt/β-catenin signaling in cardiomyogenesis and hematopoiesis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:19812-19817.
43. Ueno S., et al. Biphasic role for Wnt/β-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:9685-9690.
44. Nostro M.C., et al. Wnt, activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood. Cell Stem Cell 2008, 2:60-71.
45. Kwon C., et al. A regulatory pathway involving Notch1/-catenin/Isl1 determines cardiac progenitor cell fate. Nat. Cell Biol. 2009, 11:951-957.
46. Weintraub H., et al. The myoD gene family: nodal point during specification of the muscle cell lineage. Science 1991, 251:761-766.
47. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
48. Takahashi K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
49. Vierbuchen T., et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463:1035-1041.
50. Olson E.N. Gene regulatory networks in the evolution and development of the heart. Science 2006, 313:1922-1927.
51. Saga Y., et al. Mesp1 expression is the earliest sign of cardiovascular development. Trends Cardiovasc. Med. 2000, 10:345-352.
52. Lindsley R.C., et al. Mesp1 coordinately regulates cardiovascular fate restriction and epithelial-mesenchymal transition in differentiating ESCs. Cell Stem Cell 2008, 3:55-68.
53. Bondue A., et al. Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification. Cell Stem Cell 2008, 3:69-84.
54. David R., et al. MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signalling. Nat. Cell Biol. 2008, 10:338-345.
55. Takeuchi J.K., Bruneau B.G. Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors. Nature 2009, 459:708-711.
56. Ieda, M. et al. (2010) Direct reprogramming of cardiac fibroblasts into functional cardiomyocytes by defined factors. Cell.(in press).
57. Laugwitz K.L., et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005, 433:647-653.
58. Beltrami A.P., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114:763-776.
59. Oh H., et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:12313-12318.
60. Martin C., et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev. Biol. 2004, 265:262-272.
61. Olivey H.E., et al. Coronary vessel development: the epicardium delivers. Trends Cardiovasc. Med. 2004, 14:247-251.
62. Lepilina A., et al. A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration. Cell 2006, 127:607-619.
63. Wills A.A., et al. Regulated addition of new myocardial and epicardial cells fosters homeostatic cardiac growth and maintenance in adult zebrafish. Development 2008, 135:183-192.
64. Zhou B., et al. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 2008, 454:109-113.
65. Cai C.L., et al. A myocardial lineage derives from Tbx18 epicardial cells. Nature 2008, 454:104-108.
66. Christoffels V.M., et al. Tbx18 and the fate of epicardial progenitors. Nature 2009, 458:E8-E10.
67. Jopling C., et al. Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature 2010, 464:606-609.
68. Kikuchi K., et al. Primary contribution to zebrafish heart regeneration by gata4+ cardiomyocytes. Nature 2010, 464:601-605.
69. Gurdon J.B., Byrne J.A. The first half-century of nuclear transplantation. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:8048-8052.
70. Yamanaka S. A fresh look at iPS cells. Cell 2009, 137:13-17.
71. Boland M.J., et al. Adult mice generated from induced pluriopotent stem cells. Nature 2009, 461:91-94.
72. Zhao X., et al. iPS cells produce viable mice through tetraploid complementation. Nature 2009, 463:86-90.
73. Jacobson A.G. Influences of ectoderm and endoderm on heart differentiation in the newt. Dev. Biol. 1960, 2:138-154.
74. Lough J., Sugi Y. Endoderm and heart development. Dev. Dyn. 2000, 217:327-342.
75. Climent S., et al. Neurogenic cells inhibit the differentiation of cardiogenic cells. Dev. Biol. 1995, 171:130-148.
76. Raffin M., et al. Subdivision of the cardiac Nkx2.5 expression domain into myogenic and nonmyogenic compartments. Dev. Biol. 2000, 218:326-340.
77. Schultheiss T.M., et al. A role for bone morphogenetic proteins in the induction of cardiac myogenesis. Genes Dev. 1997, 11:451-462.
78. Schlange T., et al. BMP2 is required for early heart development during a distinct time period. Mech. Dev. 2000, 91:259-270.
79. Shi Y., et al. BMP signaling is required for heart formation in vertebrates. Dev. Biol. 2000, 224:226-237.
80. Zhang H., Bradley A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 1996, 122:2977-2986.
81. Tzahor E., Lassar A.B. Wnt signals from the neural tube block ectopic cardiogenesis. Genes Dev. 2001, 15:255-260.
82. Marvin M.J., et al. Inhibition of Wnt activity induces heart formation from posterior mesoderm. Genes Dev. 2001, 15:316-327.
83. Schneider V.A., Mercola M. Wnt antagonism initiates cardiogenesis in Xenopus laevis. Genes Dev. 2001, 15:304-315.
84. Lickert H., et al. Formation of multiple hearts in mice following deletion of beta-catenin in the embryonic endoderm. Dev. Cell 2002, 3:171-181.